首页> 美国卫生研究院文献>Oncology Letters >Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique
【2h】

Flattening filter-free technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy: A clinical comparison with the flattening filter technique

机译:立体定向身体放射疗法的体积调制弧光治疗中的无展平过滤器技术:与展平过滤器技术的临床比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study sought to evaluate the impact of the flattening filter-free (FFF) technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy. Its clinical safety and availability were compared with the flattening filter (FF) method. The cases of 65 patients who underwent lung volumetric modulated arc therapy-stereotactic body radiotherapy (VMAT-SBRT) using FF or FFF techniques were reviewed. A total of 55 Gy/4 fractions (fr) was prescribed for peripheral lesions or 56 Gy/7 fr for central lesions. The total monitor units (MU), treatment time, dose to tumors, dose to organs at risk, tumor control (local control rate, overall survival, progression-free survival) and adverse events between cases treated with FF and cases treated with the FFF technique were compared. A total of 35 patients were treated with conventional FF techniques prior to November 2014 and 30 patients were treated with FFF techniques after this date. It was revealed that the beam-on time was significantly shortened by the FFF technique (P<0.01). Other factors were similar for FFF and FF plans in respect to conformity (P=0.95), homogeneity (P=0.20) and other dosimetric values, including total MU and planning target volume/internal target volume coverage. The median follow-up period was 18 months (range, 2–35). One-year local control rates were 97.1 and 90.0% in the FF group and FFF groups, respectively (P=0.33). Grade 3 pneumonitis was observed in 5.8% of FF patients and 3.4% of FFF patients (P=1.00). No other adverse events ≥grade 3 were observed. The results of the study suggest that VMAT-SBRT using the FFF technique shortens the treatment time for lung SBRT while maintaining a high local control rate with low toxicity.
机译:本研究试图评估扁平化无滤镜(FFF)技术在肺立体定向放射治疗的体积调制电弧治疗中的影响。将其临床安全性和实用性与扁平过滤器(FF)方法进行了比较。回顾了65例使用FF或FFF技术进行肺容积调制电弧疗法-立体定向放射疗法(VMAT-SBRT)的患者的病例。对于周围病变,总共开出了55 Gy / 4分数(fr),对于中心病变,开出了56 Gy / 7 fr的分数。 FF治疗患者与FFF治疗患者之间的总监测单位(MU),治疗时间,肿瘤剂量,高危器官剂量,肿瘤控制(局部控制率,总生存率,无进展生存)和不良事件技术进行了比较。在2014年11月之前,共有35例患者接受了常规FF技术的治疗,在此日期之后,共有30例患者接受了FFF技术的治疗。结果表明,通过FFF技术可以显着缩短光束接通时间(P <0.01)。 FFF和FF计划在一致性(P = 0.95),同质性(P = 0.20)和其他剂量值(包括总MU和计划目标数量/内部目标数量覆盖率)方面,其他因素相似。中位随访期为18个月(范围2–35)。 FF组和FFF组的一年局部控制率分别为97.1%和90.0%(P = 0.33)。在5.8%的FF患者和3.4%的FFF患者中观察到3级肺炎(P = 1.00)。没有观察到其他≥3级的不良事件。研究结果表明,使用FFF技术的VMAT-SBRT可以缩短肺SBRT的治疗时间,同时保持较高的局部控制率和低毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号